Related Experiment Video
Updated: Mar 1, 2026

Advanced Compositional Analysis of Nanoparticle-polymer Composites Using Direct Fluorescence Imaging
Published on: July 19, 2016
Cell uptake of mixtures of different-sized nanoplastics: Interplay and mechanism
Jie Liu1, Yuan-Yuan Liu1, Yuan Guo1
1Institute of Nanochemistry and Nanobiology, Shanghai University, Shanghai 200444, China.
Abstract:
Nanoplastics in the real world always exhibit a wide size distribution. Is the endocytosis mechanism of mixed-sized nanoplastics different from that of single-sized ones? To answer this fundamental question, herein, the cellular uptake of polystyrene nanoplastics of 50 nm (G50PS, 2.5-10 μg/mL) and 100 nm (R100PS, 10-60 μg/mL), with a number ratio range of 0.5:1-12:1, was investigated under co-exposure conditions. The results show that, compared to single exposure, the cellular uptake of G50PS is generally enhanced (by up to 74.2 %) by R100PS, because R100PS can easily trigger the clathrin-mediated endocytosis, bringing nearby G50PS into cells. The effect of G50PS on the uptake of R100PS is more complicated, especially in serum-containing medium, both enhancement (up to 71.3 %) and inhibition (up to 38.2 %) by G50PS are observed, depending on the mixing conditions. A mechanism involving protein coronas is proposed to explain the endocytic behaviors of R100PS in serum-containing medium: the competition of G50PS for the limited preferred serum proteins changes the protein corona of R100PS, thereby altering its uptake depending on the concentration and ratio of G50PS and R100PS. This finding reveals the complex nature of nanoplastics-bio interactions and sheds light on the evaluation of nanoplastic toxicity.
Related Concept Videos
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...

